The invention concerns a 2',2'-difluoro-2'-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing said compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.

Gemcitabine derivatives nanoparticles

STELLA, Barbara;ROCCO, Flavio;CATTEL, Luigi;
2007

Abstract

The invention concerns a 2',2'-difluoro-2'-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing said compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.
CN101061131
CENTRE NAT RECH SCIENT (FR); UNIV PARIS SUD PARIS 11 (FR); ROCCO FLAVIO (IT)
Gemcitabine; nanoparticles
RENOIR JM; STELLA B; ROCCO F; ROSILIO V; CATTEL L; COUVREUR P
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/45637
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact